Showing results (51-60 of 128) with videos related to

Sort By:
Pageof 13
Muscle & Nerve|November 24, 2021
Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS-R item scores in pivotal study MCI186-19Benjamin Rix Brooks, Erik P Pioro, Jonathan Katz, et al.
Neurology|July 11, 2020
A prospective harmonized multicenter DTI study of cerebral white matter degeneration in ALSSanjay Kalra, Hans-Peter Müller, Abdullah Ishaque, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|April 16, 2019
Post-hoc analyses of the edaravone clinical trials Study 16 and Study 19: a step toward more efficient clinical trial designs in amyotrophic lateral sclerosisJoseph M Palumbo, Jean Hubble, Stephen Apple, et al.
Muscle & Nerve|August 11, 2021
Gold Coast diagnostic criteria: Implications for ALS diagnosis and clinical trial enrollmentSteve Vucic, Toby A Ferguson, Catherine Cummings, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 3, 2024
International network for ALS research and care (INARC)Juliette Foucher, Tommy M Bunte, Vanessa Bertone, et al.
Expert Review of Neurotherapeutics|August 30, 2023
Oral Edaravone - Introducing a Flexible Treatment Option for Amyotrophic Lateral SclerosisGary L Pattee, Angela Genge, Philippe Couratier, et al.
JAMA Neurology|September 11, 2023
Efficacy and Safety of Ravulizumab, a Complement C5 Inhibitor, in Adults With Amyotrophic Lateral Sclerosis: A Randomized Clinical TrialAngela Genge, Leonard H van den Berg, Glen Frick, et al.
The Lancet. Neurology|September 18, 2021
Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trialMerit Cudkowicz, Angela Genge, Nicholas Maragakis, et al.
Journal of Neurology|June 12, 2025
Changes in corticosteroid and non-steroidal immunosuppressive therapy with long-term zilucoplan treatment in generalized myasthenia gravisChanna Hewamadduma, Miriam Freimer, Angela Genge, et al.
Muscle & Nerve|October 18, 2019
Long-term edaravone efficacy in amyotrophic lateral sclerosis: Post-hoc analyses of Study 19 (MCI186-19)Jeremy Shefner, Terry Heiman-Patterson, Erik P Pioro, et al.
Pageof 13